Back
Nasdaq First North IPOs
Sisu Partner advised Faron Pharmaceuticals on dual listing on Nasdaq First North Growth Market Finland
Nasdaq announces that trading in Faron Pharmaceuticals Oy shares (short name: FARON) commence on December 3, 2019 on Nasdaq First North Growth Market Finland.
Sisu Partners advised Faron Pharmaceuticals on the dual listing and continues to act as the company’s Certified Adviser.
Contact us
Let's make your next deal a successful one.
Interested in knowing more about our services or how we can assist your company?
Get in touch. We are more than happy to schedule a meeting with you.
Visit us
Eteläesplanadi 12
00130 Helsinki
Finland
